IL135520A0 - 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application - Google Patents

8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application

Info

Publication number
IL135520A0
IL135520A0 IL13552098A IL13552098A IL135520A0 IL 135520 A0 IL135520 A0 IL 135520A0 IL 13552098 A IL13552098 A IL 13552098A IL 13552098 A IL13552098 A IL 13552098A IL 135520 A0 IL135520 A0 IL 135520A0
Authority
IL
Israel
Prior art keywords
azabicyclo
octane
preparation
therapeutic application
methanamine derivatives
Prior art date
Application number
IL13552098A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9712580A external-priority patent/FR2769628B1/fr
Priority claimed from FR9712583A external-priority patent/FR2769629B1/fr
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IL135520A0 publication Critical patent/IL135520A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL13552098A 1997-10-09 1998-10-07 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application IL135520A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9712580A FR2769628B1 (fr) 1997-10-09 1997-10-09 Derives de n-(2,3-dihydro-1h-inden-2-yl)-n-propyl-8- azabicyclo[3.2.1.]octane-3-methanamine, leur preparation et leur application en therapeutique
FR9712583A FR2769629B1 (fr) 1997-10-09 1997-10-09 Derives de 8-azabicyclo[3.2.1]octane-3-methanamine, leur preparation et leur application en therapeutique
PCT/FR1998/002137 WO1999019325A1 (fr) 1997-10-09 1998-10-07 Derives de 8-azabicyclo [3.2.1] octane-3-methanamine en tant que ligands des recepteurs de dopamine d2 et d3 et de serotonine 5ht1a et 5ht2

Publications (1)

Publication Number Publication Date
IL135520A0 true IL135520A0 (en) 2001-05-20

Family

ID=26233854

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13552098A IL135520A0 (en) 1997-10-09 1998-10-07 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
IL135520A IL135520A (en) 1997-10-09 2000-04-06 History of N-Converted-8-Benz (F) Il-8-Azabicyclo [1.2.3] Octane-3-Methanamine, and Pharmaceutical Preparations Containing Them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL135520A IL135520A (en) 1997-10-09 2000-04-06 History of N-Converted-8-Benz (F) Il-8-Azabicyclo [1.2.3] Octane-3-Methanamine, and Pharmaceutical Preparations Containing Them

Country Status (31)

Country Link
US (1) US6221879B1 (no)
EP (1) EP1021442B1 (no)
JP (1) JP4505135B2 (no)
KR (1) KR20010015717A (no)
CN (1) CN1140526C (no)
AR (1) AR017300A1 (no)
AT (1) ATE212631T1 (no)
AU (1) AU746935B2 (no)
BG (1) BG64859B1 (no)
BR (1) BR9812752A (no)
CA (1) CA2305468C (no)
CO (1) CO5011097A1 (no)
CZ (1) CZ290679B6 (no)
DE (1) DE69803689T2 (no)
DK (1) DK1021442T3 (no)
EE (1) EE04347B1 (no)
ES (1) ES2171306T3 (no)
HK (1) HK1029108A1 (no)
HU (1) HUP0102086A3 (no)
IL (2) IL135520A0 (no)
NO (1) NO325170B1 (no)
NZ (1) NZ503829A (no)
PL (1) PL186998B1 (no)
PT (1) PT1021442E (no)
RU (1) RU2203281C2 (no)
SI (1) SI1021442T1 (no)
SK (1) SK283080B6 (no)
TR (1) TR200000942T2 (no)
TW (1) TW444014B (no)
UA (1) UA58476C2 (no)
WO (1) WO1999019325A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689806B1 (en) 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
EP1812389B1 (en) * 2004-10-14 2011-08-17 Abbott GmbH & Co. KG Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
US7297704B2 (en) 2005-02-17 2007-11-20 Wyeth Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives
AU2011225095C1 (en) 2010-03-11 2017-01-19 Sumitomo Dainippon Pharma Co., Ltd. N-Acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
WO2016092546A1 (en) 2014-12-09 2016-06-16 Ezekiel Golan Binge behavior regulators
CN107406370A (zh) 2014-12-09 2017-11-28 以西结·戈兰 酒精饮料替代品
KR102128782B1 (ko) 2018-09-20 2020-07-01 한양대학교 에리카산학협력단 트로페인(Tropane) 알칼로이드 화합물 및 순차적 산화반응을 이용한 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59004A0 (en) 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
JPS5592384A (en) * 1978-12-30 1980-07-12 Beecham Group Ltd Compound having pharmacological activity
IL61642A0 (en) * 1979-12-20 1981-01-30 Beecham Group Ltd Aniline derivatives,their preparation and pharmalceutical compositions containing them
US4910302A (en) 1988-12-19 1990-03-20 American Home Products Corporation Psychotropic polycyclic imides
FR2659323B1 (fr) * 1990-03-07 1992-06-12 Synthelabo Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.
FR2681320B1 (fr) 1991-09-12 1994-01-14 Synthelabo Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
FR2681325B1 (fr) 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
FR2702211B1 (fr) 1993-03-04 1995-06-02 Pf Medicament Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
CN1140526C (zh) 2004-03-03
SK5042000A3 (en) 2001-03-12
CZ20001278A3 (cs) 2000-07-12
EE04347B1 (et) 2004-08-16
US6221879B1 (en) 2001-04-24
ATE212631T1 (de) 2002-02-15
UA58476C2 (uk) 2003-08-15
BR9812752A (pt) 2000-08-29
BG64859B1 (bg) 2006-07-31
HK1029108A1 (en) 2001-03-23
NO325170B1 (no) 2008-02-11
AU9446898A (en) 1999-05-03
NZ503829A (en) 2002-03-28
AR017300A1 (es) 2001-09-05
EP1021442A1 (fr) 2000-07-26
DK1021442T3 (da) 2002-05-13
TR200000942T2 (tr) 2000-09-21
BG104309A (en) 2001-05-31
CA2305468C (en) 2007-09-25
PL186998B1 (pl) 2004-04-30
HUP0102086A3 (en) 2002-09-30
CO5011097A1 (es) 2001-02-28
AU746935B2 (en) 2002-05-09
ES2171306T3 (es) 2002-09-01
NO20001810L (no) 2000-06-09
SI1021442T1 (en) 2002-08-31
PL339764A1 (en) 2001-01-02
TW444014B (en) 2001-07-01
CN1281455A (zh) 2001-01-24
SK283080B6 (sk) 2003-02-04
DE69803689T2 (de) 2002-10-10
HUP0102086A2 (hu) 2001-12-28
CZ290679B6 (cs) 2002-09-11
CA2305468A1 (en) 1999-04-22
IL135520A (en) 2007-07-24
NO20001810D0 (no) 2000-04-07
KR20010015717A (ko) 2001-02-26
DE69803689D1 (de) 2002-03-14
EP1021442B1 (fr) 2002-01-30
PT1021442E (pt) 2002-06-28
JP2001519431A (ja) 2001-10-23
EE200000207A (et) 2001-04-16
RU2203281C2 (ru) 2003-04-27
JP4505135B2 (ja) 2010-07-21
WO1999019325A1 (fr) 1999-04-22

Similar Documents

Publication Publication Date Title
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
NZ314419A (en) Substituted 2,4-aryl-3-hydroxyalkyl pyridines; preparation and medicaments
HUP9802433A3 (en) 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
HU9800743D0 (en) Dithiolan derivatives, their preparation and their therapeutic effect
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
HUP9801910A3 (en) Dolastatin derivatives, their preparation and use
AU4071295A (en) 3-phenylisoquinol-1(2H)-one derivatives, their preparation and their therapeutic application
ZA963485B (en) Azacycloalkane derivatives, their preparation and their application in therapy
HUP9904206A3 (en) 1,4-diazabicyclo[2.2.2.]oct-2-ylmethyl derivatives,their preparation and therapeutic application
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
HK1014938A1 (en) Oxazolidinone derivatives, their preparation and therapeutical use
AU1243399A (en) Imidazole derivatives, preparation and therapeutic application thereof
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
GR3035493T3 (en) Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
ZA9610251B (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
AU3153199A (en) Azacycloalkane derivatives, preparation and therapeutic application
ZA975771B (en) 1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, their preparation and their therapeutic application.
ZA976828B (en) 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine-3-acetic acid derivatives, their preparation and their application in therapy.
ZA973124B (en) 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo[3.2.1]octane derivatives, their preparation and their therapeutic application.
AU1566599A (en) 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, preparation and therapeutic application

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed